CA2751218C - Formulation pour perte de poids - Google Patents

Formulation pour perte de poids Download PDF

Info

Publication number
CA2751218C
CA2751218C CA2751218A CA2751218A CA2751218C CA 2751218 C CA2751218 C CA 2751218C CA 2751218 A CA2751218 A CA 2751218A CA 2751218 A CA2751218 A CA 2751218A CA 2751218 C CA2751218 C CA 2751218C
Authority
CA
Canada
Prior art keywords
fruit
weight
leaf
mentha
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2751218A
Other languages
English (en)
Other versions
CA2751218A1 (fr
Inventor
Shawn Shirazi
James Akrong
Phil Apong
Raza Bashir
Craig Wissent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northern Innovations Holding Corp
Original Assignee
Northern Innovations Holding Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northern Innovations Holding Corp filed Critical Northern Innovations Holding Corp
Priority to CA2751218A priority Critical patent/CA2751218C/fr
Publication of CA2751218A1 publication Critical patent/CA2751218A1/fr
Application granted granted Critical
Publication of CA2751218C publication Critical patent/CA2751218C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un produit de perte de poids comprend un mélange dAlchemilla vulgaris, dOlea europaea, de Cuminum cyminum et de Mentha longiflora (dans la proportion en poids de 12:10:5:4), auquel des ingrédients supplémentaires ont été ajoutés pour augmenter lefficacité de la perte de poids. Les ingrédients supplémentaires peuvent comprendre, sans que ce soit limitatif, du gamma-oryzanol, de la caféine, de la cirsimarine, de la fucoxanthine, des guggulstérones, de lévodiamine, de la forskoline, de la sclaréolide, du chrome, de lacide hydroxycitrique, de lacide pinolénique, de lacide linoléique conjugué, de la protéine de pomme de terre, de la cétone de framboise, de la capsaïcine, de la synéphrine, de la déhydroépiandrostérone, de la phényléthylamine, de lorlistat, du glucomannane ou de la vitamine C, ou des sources de ceux-ci, ainsi que des ingrédients dorigine végétale comme la guarana, du yerba mate, de la damiana, du thé vert, du grain de café vert, de la cannelle, du haricot blanc, de la garcinia cambogia, du cactus nopal, de lhoodia, de la yohimbine, de la malpighia glabra, de lEurycoma Longifolia, du Caralluma Fimbriata, du Citrus aurantium, du Gymnema Sylvestre, du Lyceum barbarurn, de laloès, de la Cayenne, de la grenade, du bleuet, de la myrtille ou des extraits de tels ingrédients dorigine végétale, et des sources végétales dantioxydants. Un ingrédient supplémentaire préféré est la caféine fournie par de la caféine anhydre, du coffea arabica, du coffea canephora, du camellia sinensis, de lIlex paraguariensis, de la guarana, du Theobroma cacao et de la noix de kola. Dautres ingrédients supplémentaires peuvent également être utilisés conformément aux formulations décrites particulières.
CA2751218A 2011-08-31 2011-08-31 Formulation pour perte de poids Expired - Fee Related CA2751218C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2751218A CA2751218C (fr) 2011-08-31 2011-08-31 Formulation pour perte de poids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2751218A CA2751218C (fr) 2011-08-31 2011-08-31 Formulation pour perte de poids

Publications (2)

Publication Number Publication Date
CA2751218A1 CA2751218A1 (fr) 2013-02-28
CA2751218C true CA2751218C (fr) 2019-09-17

Family

ID=47751914

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2751218A Expired - Fee Related CA2751218C (fr) 2011-08-31 2011-08-31 Formulation pour perte de poids

Country Status (1)

Country Link
CA (1) CA2751218C (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105687042A (zh) * 2016-03-13 2016-06-22 佛山市芊茹化妆品有限公司 含有马铃薯提取物具有减肥功效的化妆品及其制备方法
US12285456B2 (en) 2018-03-20 2025-04-29 Exerkine Corporation Weight management composition
AU2019239797B2 (en) * 2018-03-20 2024-04-04 Exerkine Corporation Weight management composition

Also Published As

Publication number Publication date
CA2751218A1 (fr) 2013-02-28

Similar Documents

Publication Publication Date Title
US9220741B2 (en) Weight loss formulation
US20050249827A1 (en) Nutritional composition which promotes weight loss, burns calories, increases thermogenesis, supports energy metabolism and/or suppresses appetite
AU2006225005A1 (en) Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition
CN104509919A (zh) 一种功能性营养素饮料
CA2751218C (fr) Formulation pour perte de poids
KR100372783B1 (ko) 항스트레스 효과를 갖는 기능성 다류 조성물
US20060210653A1 (en) Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition
US20140255524A1 (en) Alpha-gpc dietary supplements for weight loss and/or increasing or maintaining lean body mass
US8840937B2 (en) Composition and method for recovery from mild traumatic brain injury
US7943183B2 (en) Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition
US20200214325A1 (en) Protein Supplement System
US10391139B2 (en) Blood pressure reduction with dietary supplements
CA2446254C (fr) Nouvelles compositions synergetiques de vitamines, de mineraux et d'oligoelements pour stimuler l'elimination des depots de lipide intracellulaire
US20250073201A1 (en) Compositions and methods for treating acute alcohol intake
US20050266096A1 (en) New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits
CA2808120A1 (fr) Preparation a deux phases et son utilisation pour le traitement de l'herpes
KR101100904B1 (ko) 세포내 지질 부착물 제거를 자극하는 비타민, 미네랄 및미량원소로 이루어진 새로운 상승작용성 조성물
JP2006104080A (ja) 痛風と尿酸による血流障害の予防又は治療効果のある組成物及び健康食品。
AU2009100176A4 (en) Nutritional supplements for coffee
HK1085655A (en) Synergic compositions comprising vitamins, minerals and trace elements to stimulate removal of intracellular lipids
EP1598063A1 (fr) Compositions synergiques de vitamines, de minéraux et d'oligo-éléments pour stimuler l'élimination des lipides intracellulaires
AT10512U1 (de) Mikronährstoffpräparat, für die nutritive ergänzung zur migräne-prophylaxe
EP2605784A1 (fr) Préparation à deux phases et son utilisation pour le traitement de l'herpès

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160525

MKLA Lapsed

Effective date: 20220831